4.20 USD
↗ 0.20 (5.00%)PRE MARKET (AS OF 07:36 AM EDT)
CAMP4 Therapeutics Corporation Common Stock
CAMPNASDAQ • USD
Market: OPEN
Shares of CAMP4 Therapeutics Corporation Common Stock (CAMP) are trading at $4.20. The stock presents a bearish profile across the board: technical indicators signal "Strong Sell" and our fundamental models agree with a "Sell" rating. This is driven by a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, exceptional Return on Equity (15475.3%) and a bearish Death Cross on the long-term moving averages. On the valuation front, CAMP trades at elevated multiples relative to its peers, earning a "Richly Valued" assessment.
Technical & fundamental data as of Oct 2, 2026.
Open?$4.05
High?$4.20
Low?$4.05
Prev. Close?$4.00
Volume?946
Avg. Volume?305.1K
VWAP?$4.06
Rel. Volume?0.00x
Bid / Ask
Bid?$3.09 × 100
Ask?$5.08 × 100
Spread?$1.99
Midpoint?$4.09
Valuation & Ratios
Market Cap?251.0M
Shares Out?62.8M
Float?28.8M
Float %?55.5%
P/E Ratio?N/A
P/B Ratio?-362.21
EPS?-$1.71
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Camp4 Therapeutics Corp is a clinical-stage biopharmaceutical company pioneering the discovery and development of regulatory RNA-based therapeutics to upregulate gene expression and restore healthy protein levels to treat various genetic diseases. The company focuses on genetic diseases of the central nervous system and liver. Its pipeline products include CMP-CPS-001 and CMP-SYNGAP. The company operates as a single operating segment, R&D, which engages in the development of a new class of RNA-based therapeutics to treat a broad range of genetic diseases.
Themes
Employees
48
Market Cap
251.0M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2024-10-11
Address
100 TALCOTT AVENUE
WATERTOWN, MA 02472
Phone: 617-651-8867
WATERTOWN, MA 02472
Phone: 617-651-8867
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-1/3)
Short-Term (Ripple)?▲ Bullish(+2/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?0
Momentum?35
Short Sent.?59
Piotroski F-Score?0/9Weak
Altman Z-Score?-4.47Distress
Confidence?53%Low
Short InterestModerate
Short % of Float?3.44%Low
Short Interest?992.7K
Days to Cover?3.6
Free Float28.8M
Avg Daily Volume273.8K
Settlement Date2026-09-15
Financial Health
Current Ratio?4.70Strong
Quick Ratio?4.70Strong
Cash Ratio?4.51Strong
Debt/Equity?-0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score67/100
P/E?N/A▾
P/B?-362.21CHEAP▾
S&P97
P/S?59.54HIGH▾
Peers100
S&P3
P/FCF?N/A▾
EV/EBITDA?-3.3CHEAP▾
S&P97
EV/Sales?39.05HIGH▾
Peers100
S&P3
Returns & Efficiency
ROE?15,475.3%STRONG▾
Peers50
S&P97
ROA?-114.8%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-28720000
Enterprise Value?$164.6M
Fundamentals ratios updated end of day